Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MRNA)

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year

Accesswire 9 days ago

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

PR Newswire 13 days ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

Accesswire 13 days ago

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

Accesswire November 7, 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

PR Newswire November 5, 2024

Shareholder Notice to Long-Term Shareholders of Moderna, Inc. (MRNA)

Newsfile November 3, 2024

Moderna to Present at Upcoming Conferences in November 2024

Accesswire October 31, 2024

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Business Wire October 28, 2024

Moderna Named a Top Employer by Science for Tenth Consecutive Year

Accesswire October 24, 2024
View More News ››

Opinion & Analysis (NDAQ:MRNA)

Rich TV Live's Stocks to Watch this week (Aug. 23, 2024)

Rich TV Live August 23, 2024

Rich TV Live's Stocks to Watch this week (Aug. 16, 2024)

Rich TV Live August 16, 2024

Memphasys, Moderna, Paion - Investments in solutions with potential

Stockhouse Editorial June 2, 2020

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data

Streetwise Reports May 19, 2020

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

Streetwise Reports April 23, 2020

U.S.-Based Biotech 'Growing into a Giant with AI'

Streetwise Reports March 9, 2020
View More Opinion ››

Bullboard Posts (NDAQ:MRNA)

Investing in Biotech or Pharma Stocks? Pay Attention to Thes

News; $MRNA Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More2024-09-14 09:15:00 ET...
whytestocks - September 14, 2024

MRNA Price Target Alert: $65.00. Issued by Jefferies

News; $MRNA MRNA Price Target Alert: $65.00. Issued by Jefferies2024-09-12 19:00:07 ET Michael Yee from Jefferies issued a price target...
whytestocks - September 12, 2024

Cathie Wood Bought This Stock After Its 27% Drop. Should You

Breaking News: $MRNA Cathie Wood Bought This Stock After Its 27% Drop. Should You?2024-08-04 04:15:00 ET "Buy when there's...
whytestocks - August 4, 2024

Moderna Reports Second Quarter 2024 Financial Results and Pr

Just In: $MRNA Moderna Reports Second Quarter 2024 Financial Results and Provides Business UpdatesReports second quarter revenues of...
whytestocks - August 1, 2024

When the Price of (MRNA) Talks, People Listen

Breaking News: $MRNA When the Price of (MRNA) Talks, People Listen2024-06-09 03:22:00 ET Stock Traders Daily has produced this trading...
whytestocks - June 9, 2024

Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Th

Just In: $MRNA Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, | BenzingaOn CNBC@s @Mad Money Lightning...
whytestocks - May 28, 2024
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. provides contract drilling services, primarily to the oil and gas industry, in Canada and the United ...
View More »